Business Trinity Capital Invests $130 Million in Candel Therapeutics for Cancer Therapies Trinity Capital Inc. has committed $130 million in growth capital to Candel Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing viral immunotherapies aimed... Editorial7 hours ago